51/120
2.1 / 5 stars
All 120 Win/Lose results shown below
ISRG Roast Me summary
INTUITIVE SURGICAL INC (ISRG). Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Win; Revenue growth Lose; EPS growth Win.
- 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Win.
Trailing 1 year (4 quarters): 3 wins, 9 lossesLast fetched: 25 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseISRG / S&P -13.73% / 15.20% |
LoseISRG / S&P ISRG unavailable / 15.00% |
LoseISRG / S&P 21.45% / 50.40% |
| 2026-Q10/3 |
LoseISRG / S&P -18.60% / -4.33% |
LoseISRG / S&P ISRG unavailable / 11.30% |
LoseISRG / S&P 20.64% / 27.70% |
| 2025-Q42/3 |
WinISRG / S&P 26.64% / 2.65% |
LoseISRG / S&P ISRG unavailable / 9.00% |
WinISRG / S&P 22.59% / 13.40% |
| 2025-Q31/3 |
LoseISRG / S&P -17.70% / 8.12% |
LoseISRG / S&P ISRG unavailable / 4.61% |
WinISRG / S&P 21.70% / 13.45% |
| 2025-Q21/3 |
LoseISRG / S&P 9.72% / 10.94% |
LoseISRG / S&P ISRG unavailable / 4.83% |
WinISRG / S&P 23.37% / 10.63% |
| 2025-Q11/3 |
LoseISRG / S&P -5.11% / -4.27% |
LoseISRG / S&P ISRG unavailable / 4.98% |
WinISRG / S&P 23.29% / 10.57% |
| 2024-Q42/3 |
WinISRG / S&P 6.25% / 2.41% |
LoseISRG / S&P ISRG unavailable / 5.25% |
WinISRG / S&P 27.63% / 6.15% |
| 2024-Q32/3 |
WinISRG / S&P 10.43% / 5.89% |
LoseISRG / S&P ISRG unavailable / 5.89% |
WinISRG / S&P 46.35% / 6.11% |
| 2024-Q22/3 |
WinISRG / S&P 11.47% / 4.28% |
LoseISRG / S&P ISRG unavailable / 5.38% |
WinISRG / S&P 45.86% / 5.12% |
| 2024-Q12/3 |
WinISRG / S&P 18.30% / 10.56% |
LoseISRG / S&P ISRG unavailable / 5.71% |
WinISRG / S&P 51.37% / 5.59% |
| 2023-Q42/3 |
WinISRG / S&P 15.42% / 11.69% |
LoseISRG / S&P ISRG unavailable / 6.81% |
WinISRG / S&P 37.81% / 7.78% |
| 2023-Q31/3 |
LoseISRG / S&P -14.52% / -3.27% |
LoseISRG / S&P ISRG unavailable / 7.52% |
WinISRG / S&P 12.43% / -5.03% |
| 2023-Q22/3 |
WinISRG / S&P 33.85% / 8.74% |
LoseISRG / S&P ISRG unavailable / 9.50% |
WinISRG / S&P 1.79% / -8.57% |
| 2023-Q10/3 |
LoseISRG / S&P -3.72% / 7.50% |
LoseISRG / S&P ISRG unavailable / 10.77% |
LoseISRG / S&P -18.49% / -15.69% |
| 2022-Q41/3 |
WinISRG / S&P 41.57% / 7.56% |
LoseISRG / S&P ISRG unavailable / 11.88% |
LoseISRG / S&P -21.67% / -17.99% |
| 2022-Q30/3 |
LoseISRG / S&P -6.61% / -4.88% |
LoseISRG / S&P ISRG unavailable / 13.47% |
LoseISRG / S&P -18.53% / -1.41% |
| 2022-Q20/3 |
LoseISRG / S&P -33.47% / -16.10% |
LoseISRG / S&P ISRG unavailable / 13.71% |
LoseISRG / S&P -12.30% / 11.04% |
| 2022-Q10/3 |
LoseISRG / S&P -16.04% / -4.60% |
LoseISRG / S&P ISRG unavailable / 15.97% |
LoseISRG / S&P 24.03% / 42.23% |
| 2021-Q40/3 |
LoseISRG / S&P 8.42% / 11.03% |
LoseISRG / S&P ISRG unavailable / 15.00% |
LoseISRG / S&P 58.50% / 96.40% |
| 2021-Q31/3 |
WinISRG / S&P 8.10% / 0.58% |
LoseISRG / S&P ISRG unavailable / 10.77% |
LoseISRG / S&P ISRG unavailable / 69.42% |
| 2021-Q22/3 |
WinISRG / S&P 24.45% / 8.55% |
LoseISRG / S&P ISRG unavailable / 6.58% |
WinISRG / S&P 146.96% / 51.81% |
| 2021-Q10/3 |
LoseISRG / S&P -9.68% / 6.17% |
LoseISRG / S&P ISRG unavailable / -1.06% |
LoseISRG / S&P -7.42% / 7.39% |
| 2020-Q42/3 |
WinISRG / S&P 15.30% / 12.15% |
LoseISRG / S&P ISRG unavailable / -3.72% |
WinISRG / S&P -23.64% / -33.42% |
| 2020-Q31/3 |
WinISRG / S&P 24.52% / 8.93% |
LoseISRG / S&P ISRG unavailable / -2.04% |
LoseISRG / S&P -105.90% / -27.10% |
| 2020-Q20/3 |
LoseISRG / S&P 15.07% / 20.54% |
LoseISRG / S&P ISRG unavailable / -0.46% |
LoseISRG / S&P -82.13% / -27.11% |
| 2020-Q11/3 |
WinISRG / S&P -16.23% / -19.60% |
LoseISRG / S&P ISRG unavailable / 3.47% |
LoseISRG / S&P -59.31% / -14.75% |
| 2019-Q41/3 |
WinISRG / S&P 9.49% / 9.07% |
LoseISRG / S&P ISRG unavailable / 5.36% |
LoseISRG / S&P -59.43% / 2.99% |
| 2019-Q32/3 |
WinISRG / S&P 2.93% / 1.70% |
LoseISRG / S&P ISRG unavailable / 5.02% |
WinISRG / S&P 63.11% / 0.21% |
| 2019-Q21/3 |
LoseISRG / S&P -8.07% / 4.30% |
LoseISRG / S&P ISRG unavailable / 6.64% |
WinISRG / S&P 47.67% / 8.65% |
| 2019-Q12/3 |
WinISRG / S&P 19.14% / 13.65% |
LoseISRG / S&P ISRG unavailable / 8.12% |
WinISRG / S&P 44.51% / 14.29% |
| 2018-Q41/3 |
LoseISRG / S&P -16.56% / -13.52% |
LoseISRG / S&P ISRG unavailable / 9.05% |
WinISRG / S&P 64.47% / 18.23% |
| 2018-Q31/3 |
WinISRG / S&P 19.96% / 7.71% |
LoseISRG / S&P ISRG unavailable / 10.21% |
LoseISRG / S&P -13.57% / 19.06% |
| 2018-Q22/3 |
WinISRG / S&P 15.90% / 3.43% |
WinISRG / S&P 20.05% / 9.03% |
LoseISRG / S&P -2.28% / 14.46% |
| 2018-Q12/3 |
WinISRG / S&P 13.12% / -0.76% |
WinISRG / S&P 18.47% / 7.68% |
LoseISRG / S&P -32.07% / 12.46% |
| 2017-Q41/3 |
LoseISRG / S&P 4.68% / 6.64% |
WinISRG / S&P 15.70% / 7.03% |
LoseISRG / S&P -7.83% / 13.82% |
| 2017-Q33/3 |
WinISRG / S&P 11.81% / 4.48% |
WinISRG / S&P 14.38% / 5.68% |
WinISRG / S&P 67.96% / 17.57% |
| 2017-Q22/3 |
WinISRG / S&P 22.04% / 3.09% |
WinISRG / S&P 13.73% / 4.83% |
LoseISRG / S&P -3.57% / 17.74% |
| 2017-Q13/3 |
WinISRG / S&P 20.86% / 6.07% |
WinISRG / S&P 14.01% / 3.67% |
WinISRG / S&P 59.71% / 13.32% |
| 2016-Q42/3 |
LoseISRG / S&P -12.51% / 3.82% |
WinISRG / S&P 13.42% / 2.09% |
WinISRG / S&P 20.85% / 7.05% |
| 2016-Q32/3 |
WinISRG / S&P 9.59% / 3.85% |
WinISRG / S&P 13.47% / 0.20% |
LoseISRG / S&P -67.84% / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-28
| Metric | ISRG total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -21.29% | 20.78% |
| Annualized return | -21.29% | 20.78% |
5Y · 2021-09-01 to 2026-08-28
| Metric | ISRG total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 5.17% | 83.14% |
| Annualized return | 1.01% | 12.86% |
10Y · 2016-09-01 to 2026-08-28
| Metric | ISRG total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 386.15% | 319.30% |
| Annualized return | 17.13% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-25.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Edwards Lifesciences Corp (EW) | United States | $49.409B | 51.96 |
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |